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    方法：本实验采用 SPF 级 KM 小鼠 60 只，每只右前腋皮下接种 H22 肝癌细
胞，接种 7 天后，全部小鼠形成肿瘤，给予腹腔注射环磷酰胺 200mg/kg 建立移
植瘤化疗模型，随机分为 5 组：模型组、环磷酰胺(Cyclophosphamide，CTX)组、
慈济化癌保生汤(CHBD)高、中、低剂量（117g/kg、58.5g/kg、29.25g/kg）组，
每组 12 只。次日开始给药，给药 10d 后采用酶联免疫吸附法(ELISA)检测各组
小鼠血清白介素 2(IL-2)、干扰素 γ(IFN-γ)、白介素 6(IL-6)、肿瘤坏死因子 α(TNF-α)
水平, 蛋白质印迹法(Western Blot)检测各组小鼠瘤组织 IFN-γ、IL-6 蛋白表达。
分别摘取胸腺、脾脏，置于电子天平上称重，测定胸腺与脾脏指数。 
    结果：实验结果表明，CHBD 3 组胸腺、脾脏重量和脾脏指数明显高于模型
组及 CTX 组(P<0.05; P<0.01)，CHBD 高、中剂量组胸腺指数增加，与 CTX 组
和模型组比较差异极显著(P<0.01)；CHBD 3 组血清 IL-2 和 IFN-γ 含量均升高，
其中 CHBD 高、中剂量组 IL-2 与 IFN-γ 含量高于模型组和 CTX 组(P<0.05; 
P<0.01)。CHBD 3 组血清 IL-6 含量明显降低，与模型组比较差异极显著(P<0.01)；
CHBD 高剂量组血清 IL-6 含量与 CTX 组相比降低，差异有统计学意义(P<0.05）。

















学意义(P<0.05; P<0.01)。与模型组和 CTX 组比较，CHBD 3 组 IFN-γ，IL-6 蛋
白表达下降，其中 CHBD 高、中剂量组有统计学差异(P<0.01)。 






















    Background: Cancer is a desease which harm human health seriously. 
Chemotherapy is one of the classic clinical therapeutic methods for cancer, but 
chemotherapeutics kill the tumor cells without selectivity, normal cells are also killed 
at the same time, which results in huge side-effects, severely affecting living quality 
and prognosis of the patients. Ciji Hua’ai Baosheng Decoction (CHBD) is a 
traditional Chinese empirical formula set up by the Prof. Yanhui Wang according to 
many years’ clinical experience on diagnosing and treating cancer. To cancer patients, 
long-term regulating with Ciji Hua’ai Baosheng Docoction (CHBD) after 
chemotherapy can obviously ameliorating the living quality, improve the constitution, 
decrease the recurrence rate and prolong the life. The early study and research 
confirmed that Ciji Hua’ai Baosheng Granule Formula (CHBGF) could prolong the 
survival time of the mice chemotherapy model of both subcutaneous transplanted 
tumor and ascitic tumor of H22 hepatoma carcinoma cells, had some determinate 
inhibitory effects on the growth of subcutaneous transplanted tumor chemo-treated, 
and had therapeutic effect on antagonizing decrease of WBC and PLT caused by 
chemotherapy
[1]
. Based on the former preliminary study, this study investigated the 
effects of Ciji Hua’ai Baosheng Decoction (CHBD) on cytokines and immune organs 
of transplanted tumor chemotherapy model mouse with H22 hepatoma carcinoma cells 
to aim at providing modern pharmacology basis for its development and clinical 
application. 
    Method: In this study, a total of 60 specific pathogen-free Kunming mice, were 
injected subcutaneously into the right anterior armpit with H22 hepatoma carcinoma 
cells, after 7 days, mice had formed tumors and were used peritoneal injection of 
Cytoxan (CTX) (200mg/kg) to establish the mouse chemotherapy model with 
transplanted tumor, then they were randomly divided into 5 groups such as model, 
positive control (CTX) and three CHBD (117g/kg, 58.5g/kg and 29.25g/kg) groups 
with 12 mice in each group. They were administered next day after making model. 
After administering for 10 days, blood was collected through pricking eyeball, level 

















immunosorbent assay (ELISA).The expression of IFN-γ, IL-6 was detected by 
western blot. Thymus and spleen were peeled off and measured the thymus and 
spleen indices. 
    Results: The result showed that the weight of thymus and spleen, and spleen 
index in three CHBD groups were obviously higher than that of model and positive 
control groups (P<0.05; P<0.01). The thymus index in CHBD high and middle 
dosage groups was increased, which showed extremely significant difference 
compared with model and CTX groups (P<0.01). The content of serum IL-2 and 
IFN-γ in three CHBD groups was increased, and IL-2 and IFN-γ content in CHBD 
high and middle dosage groups was higher than that of model and CTX groups 
(P<0.05; P<0.01). The content of serum IL-6 in three CHBD groups was decreased 
obviously, which showed extremely significant difference compared with model 
group (P<0.01). And the content of serum IL-6 in high dosage group was decreased 
more significantly than that of CTX group (P<0.05). The content of serum TNF-α in 
three CHBD groups was increased obviously, which was more than that of model and 
CTX groups (P<0.05; P<0.01). The expression of IFN-γ and IL-6 in three CHBD 
groups was decrease obviously, and IFN-γ and IL-6 expression in CHBD high and 
middle showed extremely significant difference compare with model and CTX 
groups (P<0.01). 
    Conclusion: The results of our current study clearly suggest that a certain 
concentration of Ciji Hua’ai Baosheng Decoction can improve the postchemotherapy 
immune organs weight and index of the chemotherapy model mice of transplanted 
tumor with H22 hepatoma carcinoma cells; Ciji Hua’ai Baosheng Decoction could 
improve the content of serum IL-2, IFN-γ, TNF-α and could decrease the content of 
serum IL-6, and its possible mechanism may be related with regulating some 
cytokines and protecting the immune organs to strengthen the body’s immunologic 
function to play the effect on anticancer. Ciji Hua’ai Baosheng Decoction could down 
regulate the expression of IFN-γ and IL-6, and its possible possible mechanism may 
be related with improving tumor microenvirolunent, suppress the growth of tumor. 
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英文缩写 英文全称 中文全称 
CHBD Ciji Hua’ai Baosheng Decoction 慈济化癌保生汤 
CTX Cyclophosphamide 环磷酰胺 
KM Kunming 昆明种 
IL-2 Interleukin-2 白细胞介素 2 
IL-6 Interleukin-6 白细胞介素 6 
IFN-γ Interferon-gamma 干扰素 γ 
TNF-α TNF-alpha 肿瘤坏死因子 α 
OD Optical density 光密度 
   



















第一章  前言 
现今，癌症已成为威胁人类生命健康的常见疾病，其病死率高，呈逐年攀升
的趋势。癌症的发生是一个复杂的过程，迄今为止对癌症的发病机理尚不明确。




































































慈济化癌保生汤：由橘皮 10g、炒白术 12g、茯苓 30g、牡蛎 50g、枳壳 5g、
山楂 10g、丹参 50g、党参 12g、补骨脂 10g、酸枣仁 25g、紫苏子 25g、厚朴 5g、






TEMED 美国 Sigma 
Western Blot相关抗体 美国 Santa Cruz Biotech 
Fermentas 蛋白Marker 北京巴克艾生物科技有限公司 
ECL检测试剂盒 Vigorous P004 威格拉斯生物技术（北京）有限公司 
小鼠 IL-2 ELISA试剂盒 武汉华美生物工程有限公司 
小鼠 IFN-γ ELISA试剂盒 武汉华美生物工程有限公司 
小鼠 IL-6 ELISA试剂盒 武汉华美生物工程有限公司 


















PVDF 膜 德国Merck Millipore 
ProlinePlus 移液器 芬兰 Biohit 
DYY-6C 电泳仪 北京六一仪器厂  
DYZ-24DN 电泳槽 北京六一仪器厂 
Nr.B337874 半干型转膜仪 德国Biometra  
GNP-9080 37℃ 恒温培养箱 上海精宏实验设备有限公司  
AR1502CN 精密电子天平 奥豪斯国际贸易（上海）有限公司 
TDZ5-WS 低速自动平衡离心机 湘仪离心机仪器（湖南）有限公司 








PBS 稀释，制成肝癌细胞悬液，调整浓度为 2×107 个/ml，接种于小鼠右前腋皮下，
每只 0.2ml（约为 4×106/ml）。接种 7 天后，60 只小鼠成功形成移植瘤，环磷酰
胺按 200mg/kg 给予腹腔注射 0.2ml，建立 H22 肝癌小鼠皮下移植瘤化疗模型。 
2.2.3 药物制备 
将中药加水浸泡 30 分钟，武火煮沸后转文火煎煮 30 分钟，倒出药液，共煎 2
次，将 2 次煎煮的药液倒出，约 400ml，纱布过滤，浓缩成 (5.85g/ml、2.925g/ml、
1.4625g/ml)的药液，4℃冰箱保存。以 0.9%的氯化钠注射液稀释环磷酰胺（CTX），
调整浓度为 1.66mg/ml。 

















5%丙稀酞胺混合物, 0.13 M Tris-HCI (PH6.8), 0.1%SDS, 0.1%APS, 1.2 
µg/ml TEMED" 
2. 10×SDS 电泳缓冲液： 
Tris base 30.3g, Glycine 144.0g, SDS 10.0g, ddH2O to 1 L。 
3. Transfer Buffer 10× 转膜缓冲液  
Tris base 30.3g , Glycine 144.0g, 20%v/v methanol (Fresh!), ddH2O to 1 L。 
4.TBS 缓冲液(1000ml):  




称取0.25g明胶溶于100ml TBS-T中, 加热搅拌溶解, 121℃，20min高压灭菌, 4℃
保存。 
2.2.5 动物分组及给药 
60 只移植瘤化疗模型小鼠，随机分为 5 组：模型组、环磷酰胺(CTX)组、 
CHBD 高、中、低剂量组(117g/kg、58.5g/kg 、29.25g/kg)，每组各 12 只。造模成
功 24h 后开始给药：模型组予 0.9%生理盐水 0.2ml/10g 每日灌胃 1 次；CTX 组按
(33.33mg/kg, 1.66mg/mL, 0.2mL/10g)，每 2d 腹腔注射一次；CHBD 高剂量组
(5.85g/mL, 0.2mL/10g)、CHBD 中剂量组(2.93g/mL, 0.2mL/10g)、CHBD 低剂量组
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